VRTXON

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation.

Meno VRTXON

Pozícia No.3636

Trhová kapitalizácia $0.00

Plne zriedená trhová hodnota $0.00

Podiel na trhu %

Objem obchodovania/trhová kapitalizácia (24 h) 18,803,241.08%

Počet coinov v obehu 3.84400459

Max. počet coinov v obehu 0

Celková ponuka 3.84400459

Rýchlosť obehu %

Dátum vydania --

Cena, za ktorú bolo aktívum prvýkrát vydané --

Celkové maximum 466.35223147502205, 2026-03-26

Najnižšia cena 414.92035330237934, 2026-05-05

Verejný blockchain VRTXON

Úvod Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation.

Sektor

Sociálne siete

• Twitter

• Oficiálna webová stránka
• Prieskumník blokov

Analýza toku finančných prostriedkov

etfindex:mc_etfindex_source Odmietnutie zodpovednosti: Údaje, ktoré poskytuje cmc a ktoré by sa nemali považovať za investičné poradenstvo.